🦊/Investors

Kairos Venture Investments, Llc β€” Full Portfolio

36 tracked investments Β· listed companies and verified rows first

Actuate Therapeuticsactuatetherapeutics.comin𝕏NASDAQ: ACTU

Actuate Therapeutics is a clinical-stage biopharmaceutical company developing elraglusib, a small-molecule GSK-3Ξ² inhibitor designed to treat difficult-to-treat cancers including pancreatic, melanoma, lung, and pediatric cancers through intravenous injection and oral tablet formulations.

BiotechFort Worth, US

Daniel Schmitt(President & Chief Executive Officer)Paul Lytle(Executive Officer)inAndrew Mazar(Executive Officer)

BoardTodd Thomson(Director)inRoger Sawhney(Director)Jason Keyes(Director)

Co-investorsIllinois VenturesBiosBios Partners

AMORPHOLOGY INCamorphology.cominβœ“ verified

Amorphology manufactures high-precision metallic components using amorphous metals and bulk metallic glass technology, enabling lower-cost production of complex parts like gearboxes for industrial and precision engineering applications.

Advanced ManufacturingDeep TechNew Materials

Douglas Hofmann(Scientific Founder)Jim Demetriades(Chairman)inAlex Andrianopoulos(Chief Executive Officer)inGlenn Garrett(Chief Technology Officer)

Actiniaactiniadetectors.com

Actinia develops radiation detector materials based on CsPbBr3 (perovskite) semiconductors to improve the resolution and reduce the dose of radiological imaging techniques such as SPECT, CT, and X-ray, with applications in medicine and security.

Deep TechMedical DevicesNew Materials

Mercouri Kanatzidis(Co-Founder)inDuck Young Chung(Co-Founder)in

BoardJosh Palmer(Acting Chief Executive Officer)in

Avvio Medicalavviomedical.com

Avvio AMEA develops kidney stone treatment technology for urological care, targeting patients and healthcare providers across Asia, the Middle East, and Africa.

BiotechHardwareHealthtechMedical DevicesSan Francisco, US

Marshall Stoller(Founder)Robert Grubbs, PhD (deceased)(Founder)Claire Mills, RDMS, RVT(Founder)Paul Molloy(CEO and Director)inBen Zadik(Executive Officer)Greg Johnstone(CFO)

Co-investorsGlobal Bridge Capital

Behavioral Signalsbehavioralsignals.comin𝕏

Behavioral Signals develops emotion recognition AI technology that analyzes speech to detect human emotions and behaviors.

AI & Machine LearningEnterprise SoftwareSaaSSales TechAthens, GR

Alex Potamianos(Founder)Shrikanth Narayanan(Founder & Chief Scientist)in

Co-investorsIn-Q-TelPresto Ventures

Clearsenseclearsense.comin

Clearsense operates the 1Clearsense Platform, a healthcare data lakehouse that unifies and manages disparate data for health systems and presents it in simplified, actionable views.

AI & Machine LearningData & InfrastructureDigital HealthHealthtechSaaSJacksonville, US

Ken Misch(Chief Financial Officer and Chief Operating Officer)inJason Rose(Chief Executive Officer)inMatt Henderson(Chief Compliance Officer and General Counsel)Jonathan Cook(Chief Technology Officer)inWirick Glenn(Chief Commercial Officer)Eugene Scheurer(Executive Officer, Director)

Co-investorsHealth Catalyst CapitalHealthQuest Capital

Compelloncompellon.comSeries A Β· Apr 2016 Β· $7M

Rancho Santa Margarita, US

Mark Pollard(Executive Officer, Director)Kenneth Charhut(Executive Officer, Director)Nikolai Liachenko(Director)

BoardJerry Pellizzon(Director)

Co-investorsKairos Venture Partners

CytoDelcytodel.com

Biopharmaceutical company using molecular biology to produce recombinant derivatives of botulinum neurotoxin for customized applications.

BiotechNew York, US

Charles Weiss(Director)Andre Gudger(Director)Philip A. Band(Executive Officer, Director)

BoardMargery Fischbein(Director)

Co-investorsNYU Innovation Venture Fund

Delpordelpor.comin

Delpor develops subcutaneous implant devices that deliver therapeutic drugs over extended periods (6-12 months) for chronic condition treatment.

BiotechHealthtechMedical Devices

Co-investorsUlu Ventures

Foldaxfoldax.comin𝕏

Foldax develops heart valve replacement technology leveraging polymer expertise and biologic design.

Advanced ManufacturingBiotechHealthtechMedical DevicesSalt Lake City, US

Frank Maguire(Executive Officer, Director)

BoardKen Charhut(Director)George Wallace(Director)Morteza Gharib(Director)Mory Gharib(Director)

Co-investorsAngel Physicians FundMemorialCare Innovation FundKairos Venture Partners

Holoclaraholoclara.comin𝕏

Holoclara develops therapeutics derived from symbiotic intestinal organisms (helminths) that modulate inflammation, metabolism, and tissue regeneration to address chronic disease, immune-related conditions, and aging.

BiotechHealthtechLongevity

Andrea Choe(CEO / Co-Founder)inPaul W. Sternberg(Co-Founder)inFrank C. Schroeder(Co-Founder)in

Co-investorsHorizons VenturesBOLD CapitalBold Capital PartnersFREEFLOWEndurance28

Linnaeus Therapeuticslinnaeustx.comin

Clinical-stage biotech company developing small molecule agents modulating cellular differentiation for cancer and pigmentation disorders.

BiotechHaddonfield, US

Patrick T. Mooney(Executive Officer)in

BoardJames Demetriades(Director)Todd Thomson(Director)inMichael D. Poisel(Director)Chris Arendt(Director)

Co-investorsIA GlobalKairos Venture Partners

Mattiqmattiq.com

MattiQ accelerates materials science discovery using a platform for computational experimentation and design across energy, computing, transportation, and space industries.

AI & Machine LearningBiotechDeep TechNew MaterialsChicago, US

Chad A. Mirkin(Scientific Founder & Director)Dr. Andrey Ivankin(Co-Founder & CTO)Jeffrey Erhardt(Executive Officer, Director)Ben Schlatka(CEO & Director)inLouis Simpson(Director)

BoardQuinten Stevens(Director)

Co-investorsMaterial Impact

Neuro-Bioneuro-bio.com

Neuro-Bio is a privately owned biotech focused on neurodegenerative diseases, developing diagnostic and therapeutic strategies for Alzheimer's disease.

BiotechHealthtechMedical Devices

Proviviprovivi.comin𝕏Series B Β· Nov 2017 Β· $21M

AgTechSanta Monica, US

Frances Arnold(Director)inPeter Meinhold(Executive Officer)inPedro Coelho(Executive Officer)inCorey Huck(Executive Officer, Director)in

BoardGANESH KISHORE(Director)inALAN BOYCE(Director)

Co-investorsAliment CapitalPontifax AgTechSpruce Capital PartnersVivo CapitalKairos Venture PartnersXeraya Capital

PteroDynamicspterodynamics.comin𝕏

Pterodynamics develops the Transwing, an aircraft designed to support businesses seeking to reduce their operational environmental impact.

CleantechDefense TechHardwareRoboticsMoorpark, US

Matthew Graczyk(CEO)in

Co-investorsLavrock Ventures

Specter Aerospacespecteraerospace.comin𝕏

Spectera Aerospace develops propulsion and flight systems for the aerospace industry.

Deep TechDefense TechHardwareSpace TechBoston, US

Felipe Gomez del Campo(Founder)in

Co-investorsE2MC VenturesEvergreen Climate Innovationsfutureland venturesOPAMP CAPITAL

Vivodynevivodyne.comin𝕏

Vivodyne is a bio-AI company that develops lab-grown human tissues and robotic systems to generate causal biological data for therapeutic development.

AI & Machine LearningBiotechDeep TechBrisbane, US

Andrei Georgescu(Executive Officer, Director)inDongeun Huh(Executive Officer, Director)Andrei Georgescu, Ph.D.(Founder)in

BoardQuinten Stevens(Director)Alex Andrianopolous(Director)Alex Morgan(Director)in

Co-investorsBison VenturesKhosla VenturesFortius VenturesMBX Capital

Other

Tracked investments with no reachable website or further public details β€” typically companies that wound down, renamed, or were absorbed.

1200 PharmaAxial TherapeuticsDEARhealthGuRuKMLabsMidIRMixCommNanoClearnFugueNVasc, Inc.Pinpoint TherapeuticsPomeloQuicksilver BiosciencesSymbiotix BiotherapiesTPSTransient Plasma Systems (TPS)Wonder Blades

Rows marked β€œSEC filing” are inferred from directors named on the company's SEC Form D β€” public regulatory data, not a portfolio list published by the firm.